Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences

Zentalis Pharmaceuticals shares fell about 15% in pre-open trading after the company announced and priced a large underwritten public offering. The deal issues 23 million shares at $3.50 each, with an option for up to 3.45 million more. Gross proceeds are about $80.5 million to fund trials and research for azenosertib.

Zentalis Pharmaceuticals (NASDAQ:ZNTL) shares fell about 6.5% in after-hours after it announced an underwritten public offering of common stock and pre-funded warrants. The company plans to use net proceeds plus existing cash for clinical trials, regulatory filings, manufacturing, and general corporate purposes. Joint bookrunners include TD Cowen, Guggenheim, and Oppenheimer.

Zentalis Pharmaceuticals, Inc. (ZNTL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Zentalis Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Updates • Following U.S. regulatory discussions, accelerated approval strategy remains intact, supported by DENALI Part 2 • Enrollment completed in Part 2a and 2b of the DENALI trial;

ManpowerGroup reported upbeat Q2 results. Adjusted earnings were 99 cents per share, above analysts’ 95 cents estimate. Revenue increased 8% year over year to $4.86 billion, or 6% in constant currency, versus $4.72 billion expected. ManpowerGroup shares rose 5.8% to $54.63 on Friday.

Lynx Research predicts breakouts for Micron (MU) and SanDisk (SNDK), assigning targets of $1,325 and $2,450, implying 31.7% and 41.9% upside. The firm cites reduced volatility and steady buying in the memory sector. Both companies benefit from tightening supplies and AI demand. MU's volatility eased in August, while industry fundamentals remain supportive.

Postal Realty Trust (PSTL) received a BBB rating from Fitch, joining a prior KBRA rating, which may lower its funding costs. The REIT has 99.8% occupancy and aims to acquire $150-$160M in USPS-leased properties by 2026. Lower costs could aid consolidation in a fragmented market, but risks include tenant concentration and acquisition yield compression.